U.S. Physical Therapy (NYSE:USPH) Stock Price Expected to Rise, Barrington Research Analyst Says

U.S. Physical Therapy (NYSE:USPH) had its target price boosted by research analysts at Barrington Research from $110.00 to $122.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research‘s price objective would indicate a potential upside of 22.65% from the company’s previous close.

Several other research analysts also recently commented on USPH. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Finally, JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average target price of $104.25.

U.S. Physical Therapy Price Performance

USPH stock traded up $0.87 during mid-day trading on Friday, hitting $99.47. The stock had a trading volume of 148,432 shares, compared to its average volume of 191,591. The firm has a fifty day simple moving average of $86.32 and a 200 day simple moving average of $77.39. The firm has a market capitalization of $1.48 billion, a P/E ratio of -73.68, a P/E/G ratio of 2.71 and a beta of 1.16. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.56. U.S. Physical Therapy has a 52 week low of $58.19 and a 52 week high of $101.80.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.76 by $0.04. U.S. Physical Therapy had a net margin of 3.60% and a return on equity of 10.19%. The business had revenue of $222.56 million during the quarter, compared to the consensus estimate of $214.48 million. During the same period in the previous year, the business earned $0.66 earnings per share. The company’s revenue was up 12.9% on a year-over-year basis. As a group, research analysts forecast that U.S. Physical Therapy will post 2.87 EPS for the current year.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds and other institutional investors have recently bought and sold shares of USPH. Legal & General Group Plc purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $2,339,000. Renaissance Technologies LLC raised its stake in U.S. Physical Therapy by 23.4% in the first quarter. Renaissance Technologies LLC now owns 76,956 shares of the company’s stock valued at $5,769,000 after buying an additional 14,582 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth $9,087,000. Royal Bank of Canada raised its stake in shares of U.S. Physical Therapy by 22.0% during the first quarter. Royal Bank of Canada now owns 133,777 shares of the company’s stock worth $10,029,000 after purchasing an additional 24,081 shares during the last quarter. Finally, BlackRock Inc. acquired a new position in U.S. Physical Therapy during the second quarter worth $155,505,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients’ needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.